Song Xue

Song Xue is an accomplished professional in the pharmaceutical industry, currently serving as the Director at Repare Therapeutics since November 2020. Prior to this role, Song Xue held positions as Senior Principal Investigator at Cyclerion and Ironwood Pharmaceuticals from April 2019 to November 2020 and August 2012 to March 2019, respectively. Song Xue's career began at Novartis, where significant contributions were made as a Sr. Fellow from September 1998 to August 2012. Educationally, Song Xue earned a Ph.D. in Organic Chemistry from Rutgers University and a BS in Chemistry from the University of Science and Technology of China.